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ABSTRACT The genomes of human herpesvirus 6A (HHV-6A) and HHV-6B have the
capacity to integrate into telomeres, the essential capping structures of chromo-
somes that play roles in cancer and ageing. About 1% of people worldwide are car-
riers of chromosomally integrated HHV-6 (ciHHV-6), which is inherited as a genetic
trait. Understanding the consequences of integration for the evolution of the viral
genome, for the telomere, and for the risk of disease associated with carrier status is
hampered by a lack of knowledge about ciHHV-6 genomes. Here, we report an anal-
ysis of 28 ciHHV-6 genomes and show that they are significantly divergent from the
few modern nonintegrated HHV-6 strains for which complete sequences are cur-
rently available. In addition, ciHHV-6B genomes in Europeans are more closely re-
lated to each other than to ciHHV-6B genomes from China and Pakistan, suggesting
regional variation of the trait. Remarkably, at least one group of European ciHHV-6B
carriers has inherited the same ciHHV-6B genome, integrated in the same telomere
allele, from a common ancestor estimated to have existed 24,500  10,600 years
ago. Despite the antiquity of some, and possibly most, germ line HHV-6 integrations,
the majority of ciHHV-6B (95%) and ciHHV-6A (72%) genomes contain a full set of
intact viral genes and therefore appear to have the capacity for viral gene expres-
sion and full reactivation.
IMPORTANCE Inheritance of HHV-6A or HHV-6B integrated into a telomere occurs at
a low frequency in most populations studied to date, but its characteristics are
poorly understood. However, stratification of ciHHV-6 carriers in modern populations
due to common ancestry is an important consideration for genome-wide association
studies that aim to identify disease risks for these people. Here, we present full se-
quence analysis of 28 ciHHV-6 genomes and show that ciHHV-6B in many carriers
with European ancestry most likely originated from ancient integration events in a
small number of ancestors. We propose that ancient ancestral origins for ciHHV-6A
and ciHHV-6B are also likely in other populations. Moreover, despite their antiquity,
all of the ciHHV-6 genomes appear to retain the capacity to express viral genes, and
most are predicted to be capable of full viral reactivation. These discoveries repre-
sent potentially important considerations in immunocompromised patients, in partic-
ular in organ transplantation and in stem cell therapy.
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Given the complex roles that human telomeres play in cancer initiation and pro-gression and in ageing (1, 2), it is remarkable that the genomes of human
herpesviruses 6A (HHV-6A) and HHV-6B (species Human betaherpesvirus 6A and Human
betaherpesvirus 6B) can integrate and persist within them (3). Human telomeres com-
prise double-stranded DNA primarily composed of variable lengths of (TTAGGG)n
repeats and terminated by a 50- to 300-nucleotide (nt) 3= single-strand extension of the
G-rich strand. Telomeres, bound to a six-protein complex called shelterin, cap the ends
of chromosomes and prevent inappropriate double-strand break repair. They also
provide a solution to the “end replication problem” via the enzyme telomerase (4–6).
The double-stranded DNA genomes of HHV-6A and HHV-6B consist of a long unique
(U) region (143 to 145 kb) including many functional open reading frames (ORFs) (U2
to U100), flanked by identical left and right direct repeats (DRL and DRR; 8 to 10 kb)
including two ORFs (DR1 and DR6). Each DR also contains near its ends two variable
regions of telomere-like repeat arrays (T1 and T2) (7, 8), terminated by the viral-
genome-packaging sequences (PAC1 and PAC2, respectively) (9, 10). Telomeric inte-
gration by HHV-6A or HHV-6B (yielding chromosomally integrated HHV-6 [ciHHV-6])
results in loss of the terminal PAC2 sequence at the fusion point between the telomere
and DRR-T2 (11) and loss of the DRL-PAC1 sequence at the other end of the integrated
viral genome when the DRL-T1 degenerate telomere-like repeat region becomes part of
a newly formed telomere (Fig. 1A) (12).
Once the HHV-6 genome has integrated in the germ line, it can be passed from
parent to child, behaving essentially as a Mendelian trait (inherited ciHHV-6) (13–16).
The telomere carrying the ciHHV-6 genome shows instability in somatic cells, which can
result in the partial or complete release of the viral genome as circular DNA (12, 17, 18).
This could represent the first step toward viral reactivation, and in this respect,
telomeric integration may be a form of HHV-6 latency. To date, reactivation of ciHHV-6
has been demonstrated in vivo in two settings: first, in a child with X-linked severe
combined immunodeficiency who was also a carrier of inherited ciHHV-6A (19), and
second, upon transplacental transmission from two ciHHV-6 carrier mothers to their
noncarrier babies (20). Recently, it has been shown that ciHHV-6 carriers bear an
increased risk of angina pectoris (21), although it is not known whether this arises from
viral reactivation, a deleterious effect on the telomere carrying the viral genome, or
some other mechanism.
A small proportion of people worldwide are carriers of inherited ciHHV-6A or -6B,
but very little is known about the HHV-6 genomes that they harbor, although they may
influence any associated disease risk. To investigate ciHHV-6 genomic diversity and
evolution, the frequency of independent germ line integrations, and the potential
functionality of the integrated viral genomes, we analyzed 28 ciHHV-6 genomes. We
discovered that ciHHV-6 genomes are more similar to one another than to the few
sequenced reference HHV-6 genomes from nonintegrated viruses. This is particularly
marked among the ciHHV-6B genomes from Europeans. We also found that a subset of
ciHHV-6B carriers from England, Orkney, and Sardinia are most likely descendants of a
single ancient ancestor. Despite the apparent antiquity of some, possibly most, ciHHV-6
genomes, we concluded that the majority contain a full set of intact HHV-6 genes and
therefore in principle retain the capacity to generate viable viruses.
RESULTS
Selection of ciHHV-6 carriers and sequence analysis of viral genomes. To
investigate sequence variation among ciHHV-6 genomes, 28 samples were selected for
analysis: 7 with ciHHV-6A (including LEI-1501) (18) and 21 with ciHHV-6B (Table 1). The
selected samples were identified in the various populations screened (Table 2) and
included additional individuals from the London area (16), Scotland and the north of
England (22), the Leicester area of England (18), and the Generation Scotland: Scottish
Family Health Study (GS:SFHS) (R. F. Jarrett, unpublished data). The chromosomal
locations of ciHHV-6 genomes, determined by fluorescent in situ hybridization (FISH),
were available for some samples (16, 18). For other samples, the junction between the
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FIG 1 Approach to sequencing ciHHV-6 genomes. (A) Diagram showing the organization of the HHV-6 genome
following integration of a single full-length copy into a telomere. The chromosome and centromere (Cen) are
represented by blue lines and an oval. The telomere repeats are represented by red arrows. The telomere, encom-
passing DRL-T1, is indicated by the red dashed line. The junction between the chromosome and the HHV-6 genome,
encompassing telomere repeats and DRR-T2, is indicated by the dashed blue line. DRL and DRR are shown as blue boxes.
(B) Distribution of numbered PCR amplicons across the HHV-6B genome and example gel of PCR products generated
from 1-ciHHV-6B. (C) Sequence coverage for individual ciHHV-6B genomes. Each ciHHV-6B genome is shown as a single
DR (blue box) that was covered by amplicons from DRL and DRR and with U (gray box). Gaps in the coverage caused
by loss of individual amplicons at the amplicon-pooling stage are shown in white. Tandem-repeat regions that were
fully sequenced by either Illumina NGS or by the Sanger method are shown in orange. Tandem-repeat regions (e.g., T1
and R3 in HHV-6B) that were too long to be sequenced fully are shown as brown boxes. (D) Distribution of numbered
PCR amplicons across the HHV-6A genome and example gel of products generated from HAPMAP NA18999. (E)
Sequence coverage for ciHHV-6A genomes, using the same color coding as in panel C.
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viral DR8 sequence (a noncoding region near one end of the DR) and the chromosome
subtelomeric region was isolated by PCR and sequenced (discussed below). Integration
of each ciHHV-6 genome was confirmed by detection of a telomere at DRL-T1 using
single-telomere length analysis (STELA) (12) or by detection of at least one copy per cell
using droplet digital PCR (22, 23).
Each viral genome from ciHHV-6 carriers was sequenced from pooled PCR amplicons
(12, 18). Full sets of HHV-6 amplicons were readily generated (Fig. 1; see Table S1 in the
supplemental material), demonstrating the robustness of this approach for enriching
HHV-6 sequences from ciHHV-6 carriers. The HHV-6 amplicons generated from each
carrier had the expected sizes, with variation only in amplicons encompassing repeti-
tive regions (e.g., the DRR-T1 region of degenerate telomere-like repeats). This obser-
vation indicated that all of the ciHHV-6 genomes are essentially intact, with the
exception of the terminal DRR-PAC2 and DRL-PAC1 sequences lost during integration
(Fig. 1A) (11, 12).
The ciHHV-6 genome sequences were determined by short-read next-generation
sequencing (NGS), with some verification by the Sanger method. De novo assemblies of
each genome were generated with few gaps (Fig. 1). The ciHHV-6A genome reported
previously by us was included in these analyses (LEI-1501; GenBank accession no.
KT355575) (18).
Sequence similarity is greater among ciHHV-6 genomes than to nonintegrated
HHV-6 genomes. Nucleotide substitution frequencies were analyzed across the DR and
U regions of the HHV-6B genome (excluding the tandem-repeat regions R-DR, R0, R1,
R2, R3, and R4, [Fig. 1]) (9, 24) for each sequenced ciHHV-6B genome in comparison with
the two available HHV-6B reference genomes from nonintegrated strains (HST from
Japan, GenBank accession no. AB021506 [24], and Z29 from the Democratic Republic of
TABLE 1 Samples from individuals with ciHHV-6 selected for viral genome sequencing
Sample Accession no. ciHHV-6 Integration sitea Population or country
LEI-1501b KT355575 A 19q Leicester area (England)
HAPMAP NA18999 KY316047 A Japan
3A-10q26.3c KY316049 A 10q26.3 and junction isolated by PCR Southeast England
GLA_4298d KY316056 A Newcastle (England)
GLA_15137e KY316055 A Scotland
GLA_ 25506e KY316054 A Scotland
7A-17p13.3c KY316048 A 17p13.3 Southeast England
HGDP00092 KY316037 B Balochi (Pakistan)
HGDP00813 KY316036 B Han (China)
HGDP01065 KY316035 B Junction isolated by PCR Sardinia (Italy)
HGDP01077 KY316034 B Junction isolated by PCR Sardinia (Italy)
HAPMAP NA07022 (CEPH 1340.11) KY316039 B Utah Mormon (north European)
HAPMAP NA10863 (CEPH-1375.02) KY316038 B Utah Mormon (north European)
4B-11p15.5c KY316044 B 11p15.5 Southeast England
BAN519f KY316043 B Banff (Scotland)
COR264f KY316042 B Cornwall (England)
CUM082f KY316041 B Cumbria (England)
DER512f KY316040 B Junction isolated by PCR Derbyshire (England)
2B-9q34.3c KY316045 B 9q34.3 Southeast England
1-ciHHV-6Bc KY316046 B Junction isolated by PCR Southeast England
LEI-ALD KY316033 B Leicester area (England)
ORCA1622 KY316031 B Orkney
ORCA1340 KY316032 B Orkney
ORCA3835 KY316030 B Orkney
GLA_3986d KY316053 B Newcastle (England)
GLA_29221e KY316052 B Scotland
GLA_34108e KY316051 B Scotland
GLA_35629e KY316050 B Scotland
aDetermined by FISH or amplification of chromosme–ciHHV-6 junctions by PCR.
bLEI-1501 (18).
cciHHV-6 carriers (16).
dciHHV-6 carriers (22).
eciHHV-6 carriers identified in the GS:SFHS.
fSamples from the Population of British Isles study (36).
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the Congo, GenBank accession no. AF157706 [9]). The ciHHV-6B genomes show differ-
ent patterns of variation from the reference genomes, with greater divergence from
strain Z29 in the distal portion of the U region (kb 120 to 150) and across the DR (kb
1 to 8), reaching a maximum of 35 substitutions per kilobase in these regions (Fig. 2A).
Overall, there is less divergence from strain HST, although the frequency of substitu-
tions is higher in part of the U region (kb 45 to 64) than in strain Z29. To assess
sequence variation among the ciHHV-6B genomes, comparisons were made using the
genome in the European individual HAPMAP NA10863 (CEPH1375.02) as a reference.
The substitution frequency is considerably less across the viral genomes for 18/20
ciHHV-6B genomes from individuals with European ancestry, indicating greater simi-
larity among them. Notably, the other two ciHHV-6B genomes, which showed higher
substitution frequencies in this comparison, were in individuals from Pakistan and
China, HGDP00092 and HGDP00813, respectively (Fig. 2A).
Nucleotide substitution frequencies were also analyzed across each of the seven
ciHHV-6A genomes in comparison with three nonintegrated HHV-6A reference ge-
nomes (strain U1102 from Uganda [25, 26] [accession no. X83413]; strain GS from the
United States (accession no. KC465951.1 [GS1] and KJ123690.1 [GS2] [27, 28], and strain
AJ from the Gambia [accession no. KP257584.1] [29]). This analysis showed that the
ciHHV-6A genomes have similar levels of divergence from each reference genome from
nonintegrated HHV-6A and that divergence is highest across the DR and the distal part
of the U region (kb 120 to 149) (Fig. 2B). Comparisons with the ciHHV-6A LEI-1501
genome (18) as a reference also showed greater similarity among the ciHHV-6A
genomes, although the substitution frequencies are higher than among European
ciHHV-6B genomes, indicating greater diversity among the ciHHV-6A genomes se-
quenced here (30). Notably, ciHHV-6A in the Japanese individual (HAPMAP NA18999)
showed greater divergence from the other ciHHV-6A samples of European origin.
In summary, comparisons of nucleotide substitution frequencies showed that the
viral genomes in ciHHV-6B carriers are more similar to each other than they are to
reference genomes derived from clinical isolates of nonintegrated HHV-6B from Japan
(HST) and the Democratic Republic of the Congo (Z29). The ciHHV-6A genomes are also
more similar to each other than they are to the three HHV-6A reference genomes,
although this is less pronounced than among the ciHHV-6B genomes.
TABLE 2 Summary of populations screened for ciHHV-6a
Continent Region or population
No. of samples
Total
Total
ciHHV-6 ciHHV-6A ciHHV-6B
Africa Sub-Saharan Africa 105 0 0 0
North Africa 29 0 0 0
Europe North European extraction (CEPH) 136 2 0 2
British 518 7 1 6
Orkney 2,194 42b 0 42
Italy (including Sardinia) 49 2 0 2
France 52 0 0 0
Russia 42 0 0 0
Middle East Israel 134 2 2 0
South/Central Asia Pakistan 192 1 0 1
Uygur (China) 10 0 0 0
East Asia China 213 1 0 1
Japan 74 1 1 0
Others (Siberia and Cambodia) 35 0 0 0
Oceania Bougainville 17 0 0 0
New Guinea 11 0 0 0
America South America 29 0 0 0
Mexico 35 0 0 0
Total 3,875 58 4 54
aIn addition, A. J. Bell, R. F. Jarrett, and colleagues screened the Generation Scotland: Scottish Family Health
Study cohort for ciHHV-6 (R. F. Jarrett, unpublished data).
bFrequency, 1.9%.
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FIG 2 Frequencies of nucleotide substitutions in ciHHV-6 genomes compared to reference viral genomes. (A) Number of substitutions in
1-kb windows for each of the 21 ciHHV-6B genomes in comparison with the HHV-6B strain HST (Japan) and Z29 (Democratic Republic of
(Continued on next page)
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Phylogenetic analysis of ciHHV-6 and nonintegrated HHV-6 genomes. Consis-
tent with the results shown in Fig. 2, phylogenetic analysis of the U regions from 21
ciHHV-6B genomes and the HST and Z29 reference genomes (excluding the DR, the
large repeat regions, and missing data shown in Fig. 1) showed that the ciHHV-6B
genomes in HGDP00813 from China and HGDP00092 from Pakistan are outliers to the
19 ciHHV-6B genomes from individuals of European descent (Fig. 3A). A phylogenetic
network of the ciHHV-6B genomes from individuals with European ancestry showed
three clusters of 8, 3, and 5 closely related ciHHV-6B genomes (groups 1, 2, and 3,
respectively) (Fig. 3B) and three singletons (ORCA1340, COR264, and 1-ciHHV-6B).
Phylogenetic analysis of the DR alone showed that, with the exception of COR264, the
European ciHHV-6B samples showed greater similarity to the HST (Japan) reference
genome than to the Z29 (Democratic Republic of the Congo) reference genome.
However, the DRs in the two non-European ciHHV-6B samples HGDP000813 (China)
and HGDP00092 (Pakistan) did not cluster closely with those in the European ciHHV-6B
samples, again indicating these ciHHV-6B strains are distinct (Fig. 3A; see Fig. S1 in the
supplemental material).
To explore variation only within HHV-6B genes, the frequencies of substitutions in
ORFs of each of the 21 ciHHV-6B genomes were compared with those in the HST and
Z29 reference genomes and the ciHHV-6B genome in HAPMAP NA10863 (Fig. 4A). The
patterns of variation were similar to those observed across the whole genome (Fig. 2A)
and consistent with the phylogenetic analysis, showing greater similarity among
ciHHV-6B in Europeans and with the subgroups. Phylogenetic analysis of specific genes,
which were selected because they show greater sequence variation from the reference
genomes or among the ciHHV-6B genomes, generated a variety of trees that were
generally consistent with the phylogenetic analysis based on the U region but exhib-
ited less discrimination between samples or groups (Fig. 4; see Fig. S2 in the supple-
mental material). For example, the phylogenetic tree based on U90 separates the
European ciHHV-6B samples from the ciHHV-6B samples from China and Pakistan and
from the HST and Z29 reference genomes but does not subdivide the European
ciHHV-6B samples.
Phylogenetic analysis of the seven ciHHV-6A genomes and four reference genomes
(U1102 [Uganda], AJ [Gambia], and two sequences from GS [United States]) showed a
clear separation between the integrated and nonintegrated genomes (Fig. 3C and D),
with two pairs of closely related ciHHV-6A genomes (LEI-1501 and GLA_25506; 7A-
17p13.3 and GLA_15137). A similar separation of the integrated versus nonintegrated
genomes is also evident in the phylogenetic analysis of the DR alone, irrespective of the
geographic origin of the individual ciHHV-6A carrier (see Fig. S1 in the supplemental
material).
Variation within HHV-6A genes was also explored by plotting the base substitution
frequency per ORF for each of the seven ciHHV-6A samples in comparison to the three
reference genomes and the ciHHV-6A genome in LEI_1501 (Fig. 4B). The patterns of
variation are similar to those observed across the whole genome (Fig. 2B). Phylogenetic
analyses of U83, U90, and DR6, selected because they show greater sequence variation,
generally support the phylogenetic trees and networks generated from analysis of the
U and DR regions (see Fig. S3 in the supplemental material).
Overall, the sequence variation and phylogenetic analyses indicate a divergence
between the integrated and nonintegrated HHV-6 genomes but with some differences
between HHV-6A and HHV-6B. The ciHHV-6B samples from individuals with European
FIG 2 Legend (Continued)
the Congo) genomes (top and middle, respectively) and the ciHHV-6B genome from HAPMAP NA10863 (bottom). ciHHV-6B genomes from
individuals with European ancestry are represented as light-blue lines; ciHHV-6B in HGDP00813 (China), red lines; ciHHV-6B in HGDP00092
(Pakistan), black lines. (B) Number of substitutions in 1-kb windows for each of the 7 ciHHV-6A genomes in comparison with the HHV-6A
strain U1102 (Uganda), GS (United States), and AJ (Gambia) genomes (top and middle [two]) and the ciHHV-6A genome in LEI-1501
(bottom). The color key distinguishes the ciHHV-6A genomes. The x axes in all the graphs show the HHV-6B and -6A genomes with a single
DR (kb 0 to 8) followed by U (kb 9 to 150), as shown in Fig. 1C and E. Variation within the tandem-repeat regions is not shown in the
graphs.
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FIG 3 Phylogenetic analysis of ciHHV-6 and reference nonintegrated HHV-6 genomes. (A) Maximum-likelihood phylogenetic tree of 21 ciHHV-6B genomes
and two HHV-6B reference genomes (strains HST [Japan] and Z29 [Democratic Republic of the Congo]). A total of 130,412 nucleotides were analyzed,
excluding repeat regions and missing amplicons. The scale bar represents 0.0005 substitutions per site. (B) Phylogenetic network generated from the data
set used in panel A, but without the HST and Z29 genomes and the ciHHV-6B genomes from HGDP00813 (China) and HGDP00092 (Pakistan). The ciHHV-6B
genomes from Europeans in groups 1, 2, and 3 are shown as blue, orange, and green dots, respectively, and the singletons are shown as gray dots. (C)
Maximum-likelihood phylogenetic tree of seven ciHHV-6A genomes and four HHV-6A reference genomes (strains U1102 [Uganda], AJ [Gambia], and GS1
and GS2 [United States]; GS1 and GS2 are two versions of strain GS). A total of 117,900 nucleotides were analyzed, excluding repeat regions and missing
amplicons. The scale bar represents 0.002 substitutions per site. (D) Phylogenetic network generated from the data set used in panel C. The nonintegrated
HHV-6A reference genomes are shown as yellow dots. The closely related ciHHV-6A genomes are shown as pairs of red or blue dots and singletons as gray
dots (including one from Japan). The scale bars in the networks (C and D) show the number of base substitutions for a given line length. The dots are
scaled, with the smallest dot representing a single individual.
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FIG 4 Frequency of nucleotide substitutions in ciHHV-6 genes compared to those in reference viral genomes. (A) Substitution frequencies
in each gene are shown for the 21 ciHHV-6B genomes in comparison with HHV-6B strain HST (Japan) and Z29 (Democratic Republic of the
Congo) genomes (top and middle, respectively) and the ciHHV-6B genome in European HAPMAP NA10863 (bottom). The color coding
(Continued on next page)
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ancestry showed divergence from both the HST (Japan) and Z29 (Democratic Republic
of the Congo) reference genomes, although the pattern of divergence varies across the
genome. The 21 ciHHV-6B genomes from individuals with European ancestry are more
similar to one another than to the ciHHV-6B genomes from China and Pakistan and can
be subdivided into distinct groups. There is greater divergence among the seven
ciHHV-6A genomes than among the ciHHV-6B genomes, but despite this, two pairs of
closely related ciHHV-6A genomes were identified.
From these analyses, we concluded that the three groups of closely related
ciHHV-6B genomes and the pairs of ciHHV-6A genomes identified in the phylogenetic
networks (Fig. 3B and D, respectively) could represent independent integrations by
closely related strains of HHV-6B or HHV-6A. Alternatively, each group might have
arisen from a single integration event, with members sharing a common ancestor.
Further analyses were undertaken to explore these possibilities.
Comparison of tandem-repeat regions in ciHHV-6 genomes. Tandem-repeat
arrays within the human genome often show length variation as a consequence of
changes to the number of repeat units present (copy number variation). The greater
allelic diversity in these regions reflects the underlying replication-dependent mutation
processes in tandem-repeat arrays, which occur at a higher rate than base substitutions
(31). To explore diversity among the ciHHV-6B genomes further, tandem-repeat regions
distributed across the viral genome were investigated. The R-DR, R2A, R2B, and R4
repeat regions analyzed (locations are shown in Fig. 1C) showed little or no copy
number variation among the ciHHV-6B and nonintegrated reference genomes (Fig. 5A
and Table 3). Copy number variation at R1 (location shown in Fig. 1C) was greater but
did not show a clear relationship with strains of ciHHV-6B or nonintegrated HHV-6B.
Greater copy number variation was detected at the pure array of TTAGGG repeats at
DRL-T2 (location shown in Fig. 5B), with the largest number of repeats in the HHV-6B
Z29 reference genome and ciHHV-6B in HGDP00813 from China (Fig. 5A and Table 3).
Notably, the copy number variation observed at R0 (location shown in Fig. 1C)
correlates reasonably well with the groups of ciHHV-6B genomes identified in the
phylogenetic network (Fig. 3 and 5A and Table 3).
Similar analysis of repeat regions in the ciHHV-6A genomes was conducted (Table 3).
The data suggest that ciHHV-6A genomes have fewer TTAGGG repeats at DRL-T2 than
the HHV-6A reference genomes. This variation could have been present in HHV-6A
strains prior to integration, or deletion mutations that reduced the length of the DRL-T2
array may have been favored after integration (12).
To explore variation within the T1 array of degenerate telomere-like repeats in
ciHHV-6B genomes, we amplified the DRR-T1 region using the U100Fw2 and DR1R
primers and investigated the interspersion patterns of TTAGGG and degenerate repeats
at the distal end of DRR-T1 (near U100) (Fig. 5B) by using modified telomere variant
repeat mapping by PCR (TVR-PCR) (32–34). Comparison of the TTAGGG interspersion
patterns between the samples showed that the ciHHV-6B genomes clustered into
groups that share similar TVR maps in DRR-T1 (Fig. 5C). Furthermore, these interspersion
patterns differed between the groups and the singleton ciHHV-6B genomes identified
in the phylogenetic analyses. Variation around the (CA)n simple tandem repeat, located
immediately adjacent to DRL-T1 (location shown in Fig. 5B), also showed clustering into
groups that correlate with the ciHHV-6B phylogenetic analyses (Fig. 3 and 5D and Table
3). Overall, the analyses of tandem-repeat regions in the ciHHV-6B genomes are
consistent with the phylogenetic analyses.
FIG 4 Legend (Continued)
shown in the key matches that of the network in Fig. 3B as follows: European group 1, pale-blue lines; European group 2, orange lines;
European group 3, green lines; European singletons, gray lines; ciHHV-6B in HGDP00813 from China, red lines; and ciHHV-6B in HGDP00092
from Pakistan, black lines. (B) Substitution frequency in each gene for each of the 7 ciHHV-6A genomes in comparison with the HHV-6A
strain U1102 (Uganda), GS (United States), and AJ (Gambia) genomes (top and middle [two]) and the ciHHV-6A genome in European
LEI-1501 (bottom). The color key matches that of the network in Fig. 3D. The x axes of all the graphs show a single copy of DR1 and DR6,
followed by genes found in the U region.
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Ancestry of ciHHV-6B carriers in group 3. The repeat copy number variation
observed within and among groups may have arisen before or after telomeric integra-
tion of the viral genome. To investigate further how many different integration events
may have occurred among the ciHHV-6B carriers, we isolated and sequenced fragments
containing the junction between the human chromosome and the ciHHV-6B genome,
in addition to using the cytogenetic locations published previously for some samples
(Table 1) (16). The junction fragments were isolated by a trial-and-error approach, using
PCR between a primer mapping in DR8 in DRR and a variety of primers known to
anneal to different subtelomeric sequences (Fig. 6A), including primers that anneal
to the subterminal regions of some, but not all, copies of chromosome 17p (17p311
[35] and sub-T17-539 [12]). There was insufficient DNA for analysis from the sequenced
ORCA1340 (singleton) or ORCA1622 and ORCA3835 (group 3) samples (Fig. 3B). How-
FIG 5 Copy number variation in tandem-repeat loci across the HHV-6B genome. (A) Number of repeat units at loci within the DR (R-DR and DRL-T2) and U (R0,
R1, R2A, R2B, and R4) regions. Comparisons can be made among the reference nonintegrated HHV-6B strain HST (Japan) and Z29 (Democratic Republic of the
Congo) and ciHHV-6B genomes. The sample order along the x axis is as follows: HST, Z29 (mauve); European group 1 ciHHV-6B genomes (blue); European group
2 ciHHV-6B genomes (orange); European group 3 ciHHV-6B genomes (green); European singleton ciHHV-6B genomes (no highlight); ciHHV-6B in HGDP00813
from China (red); and ciHHV-6B in HGDP00092 from Pakistan (no highlight). (B) Locations of the PCR amplicons used to analyze the repeat sequences shown
in panels C and D. The black dashed line indicates the amplicon generated by the U100Fw2 and DR1R primers that were used for TVR-PCR shown in panel C.
The red dashed line indicates STELA products, generated from DR1R, that were used to analyze the (CA)n repeat shown in panel D. (C) Distribution of TTAGGG
repeats at the distal end of DRR-T1 (near U100) in ciHHV-6B genomes. If the repeat array comprises consecutive TTAGGG repeats, a ladder of bands with 6-base
periodicity should be present, and the migration distance between the rungs on the ladder should steadily decrease as the separation between the bands is
reduced (near the top of the gel, toward DR1). The observed distance between the bands in each track varies between the samples. This shows that the repeat
array is not pure (TTAGGG)n but includes intervening sequence, most likely degenerate telomere-like repeats. The patterns of repeats can be compared between
the tracks to identify samples that share the same repeat distribution at that end of DRR-T1. The ciHHV-6B samples are color coded in accordance with groupings
identified in Fig. 3: European group 1, blue; group 2, orange; group 3, green; European singletons, gray; ciHHV-6B in HGDP00813 from China, red; ciHHV-6B
in HGDP00092 from Pakistan, black. (D) Variation in copy numbers of CA repeats and adjacent 5= sequence near the start of the ciHHV-6B DRL-T1 region. The
samples are color coded as in panel C.
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TABLE 3 Variation in tandem-repeat regions among ciHHV-6
Parameter Valuef
Tandem repeat regions
in HHV-6B
Name T1 STR (CA)n R-DRa T2 R0a R1 R2Aa R2B R3 R4a
Location Adjacent to DR-T1 DR DR U1 U86 U86–U89 U86–U89 U91–U94 After U100
Length (bp) 6 2 15 6 15 12 79 12–15 104 64
Unit CA NIb TTAGGG NI NI NI NI NI NI
HSTc e 12 6 26 17 51 4 6  6
Z29c  1 4 77 13 53 4 8  4
HAPMAP NA10863  20 5 28 16 44 4 7  4
2B-9q34.3  20 5 26 19 44 4 7  4
CUM082  19 5 27 19 45 4 7  4
BAN519  19 5 28 16 44 4 7  4
GLA_3986  20 5  19 44 4 7  2
GLA_29221  19 5  19 45 4 7  4
GLA_34108  19 5  19 43 4 7  4
GLA_35629   5  19 45 4 7  4
HAPMAP NA07022  11 5 29 10 46 4 6  4
4B-11p15.5  11 5 26 10 47 4 6  4
LEI-ALD  11 5 25 10 47 4 6  4
HGDP01065  10 5 15 16 44 4 7  4
HGDP01077  10 5 19 16 43 4 7  4
DER512  10 5 21 16 43 4 7  4
ORCA1622   5  16 43 4 7  3
ORCA3835   5  16 43 4 7  3
ORCA1340     16 48 4 6  4
1-ciHHV-6B  12 5 16 16 43 4 6  4
COR264  12 9 28 19 44 4 7  2
HGDP00813  20 3 53 12 52 4 7  4
HGDP00092  1 2 19 17 55 4 11  3
Tandem-repeat regions
in HHV-6A
Name T1 T2 R5d R1 R2 R3
Location DR U41–U42 U86 U86–U89 U91–U94
Length (bp) 6 6 191 12 12–18 104–105
TTAGGG NI NI NI NI
AJc  51 1.7 52 43 8
U1102c  59 1.7 52 102 29
GS1/2c  51 1.7 52 78 8
LEI-1501  14 2.7   
GLA_25506   2.7 32  
GLA_4298   3.7 53  
HAPMAP NA18999  13 1.7   
3A-10q26.3  9 1.7 58  
GLA_15137   1.7 55  
7A-17p13.3   1.7 55  
aRepeats specific to HHV-6B. The coordinates of R-DR and R4 in HHV-6B strain HST are 5400 to 5489 and 152603 to 152986, respectively.
bNI, repeats are not identical.
cReference genomes are in boldface.
dRepeat specific to HHV-6A; the coordinates of R5 in HHV-6A strain U1102 are 68124 to 68450; the other repeats are described in references 9 and 24.
e, analysis was not completed.
fSamples that showed close phylogenetic relationship in Fig. 3 are grouped in the table, with a space between each group.
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ever, analysis of DRR-T1 and the other repeats showed that the 42 ciHHV-6B carriers
from Orkney fell into two groups that share the same length at DRR-T1 either with
ORCA1340 or with ORCA1622 and ORCA3835 (Table 3). For junction fragment analysis,
we selected ORCA1006 as a substitute for ORCA1340, since it shares the same DRR-T1
length. Similarly, ORCA1043, ORCA2119, and ORCA1263 were used as substitutes for
ORCA1622 and ORCA3835, since they share a different DRR-TI length. Using the
chromosome 17p primers, junction fragments were generated from all of the group 3
ciHHV-6B samples and from 1-ciHHV-6B (a singleton in the phylogenetic network) (Fig.
3). Using these primers, PCR products were not amplified from other ciHHV-6B samples
in this study. The sequences of seven junction fragments from group 3 ciHHV-6B
genomes (including NWA008 [36], which is another ciHHV-6B carrier with a viral
genome that belongs to group 3 [data not shown]) were similar to each other but
different from the fragment in sample 1-ciHHV-6B (Fig. 6B). These data indicate the
existence of at least two independent integration events into different alleles of the
chromosome 17p telomere, or possibly into telomeres of different chromosomes that
have similar subterminal sequences (37).
Comparison of the junction fragments from group 3 ciHHV-6B samples showed
remarkably similar TTAGGG and degenerate-repeat interspersion patterns (Fig. 6B). The
differences among the interspersion patterns are consistent with small gains or losses
that may have arisen from replication errors in the germ line after integration of the
viral genome (32). Therefore, it is most likely that the ciHHV-6B status of group 3
individuals arose from a single ancestral integration event. Using the levels of nucle-
otide substitution between the group 3 ciHHV-6B genomes, the time to the most recent
common ancestor (TMRCA) was estimated as 24,538  10,625 years ago (Table 4). This
estimate is based on the assumption that, once integrated, the ciHHV-6B genome
mutates at the same average rate as the human genome as a whole. However,
deviation from this rate would result in an under- or overestimation of the TMRCA.
FIG 6 Characterization of ciHHV-6B integration sites. (A) Diagram showing the locations of PCR amplicons used to characterize the chromosome–ciHHV-6B
junctions. The red arrows represent TTAGGG and degenerate repeats; blue arrows, primers used to amplify the chromosome–HHV-6 junction; blue dashed line,
chromosome junction amplicon used for sequence analysis. (B) Diagram showing the similarity of the TTAGGG and degenerate-repeat (see color key on the
right) interspersion patterns in the chromosome–HHV-6 junctions from individuals with group 3 ciHHV-6B genomes (DER512 to HGDP01065 [Fig. 3B]). These
interspersion patterns are distinct from that of the chromosome junction fragment isolate from 1-ciHHV-6B (singleton in Fig. 3B). The sequence on the left of
the repeats is from the chromosome subtelomeric region, and the sequence on the right is from the ciHHV-6B genome.
TABLE 4 Estimate of TMRCA for ciHHV-6B genomes in group 3
Parameter
Value
Entire group 3a
HGDP1065 and
HGDP1077
HGDP1065 and
DER512
TMRCA (yrs ago) 24,538 23,004 15,336
Standard deviation 10,625 13,281 10,844
aORCA1622 and ORCA3835 are identical across nonrepeat regions.
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Genetic intactness of ciHHV-6 genomes. The evidence for an ancient origin of
some, probably most, of the ciHHV-6B genomes analyzed, and for postintegration
mutations in repeat regions, raised the question of whether these genomes contain an
intact set of viral genes or whether they have been rendered nonfunctional by
mutation. To explore the consequences of sequence variation among the ciHHV6B
genomes, the amino acid sequences predicted from all the genes in the ciHHV-6B
genomes were aligned, and the cumulative frequencies of independent synonymous
and nonsynonymous substitutions were determined (Fig. 7A). The ratio of synonymous
to nonsynonymous substitutions varies among genes. The great majority of nonsyn-
onymous changes (amounting to 34% of the total) result in single amino acid substi-
tutions, but one substitution in the U20 stop codon of HGDP00092 is predicted to
extend the coding region by eight codons. Only one substitution, which creates an
in-frame stop codon in U14 of 1-ciHHV-6B, is predicted to terminate a coding region
prematurely. Two of the seven ciHHV-6A genomes also have in-frame stop codons, one
in U79 of GLA_15137 and the other in U83 genes of GLA_4298 (data not shown).
The 21 inherited ciHHV-6B genomes are likely to include mutations that arose before
integration and represent variation among the parental nonintegrated HHV-6B strains,
as well as mutations that arose after integration. To explore the latter, five group 3
ciHHV-6B genomes were compared (Fig. 7B). Among the 10 substitutions identified, 3
were in noncoding regions, 1 was a synonymous mutation in U77, and 6 were
nonsynonymous mutations. From these limited data, it seems likely that the accumu-
lation of mutations after integration has been random in these ciHHV-6B genomes.
DISCUSSION
In this study, we used comparative analyses to explore diversity among ciHHV-6
genomes in order to understand the factors that influence the population frequencies
of ciHHV-6 and to determine whether the integrated genomes appear to retain the
capacity for full functionality as a virus. We found that the ciHHV-6B genomes are more
FIG 7 Consequences of nucleotide substitutions across the ciHHV-6 genome. (A) Comparison of synonymous (blue) and nonsynonymous (orange) substitution
frequencies in each ciHHV-6B gene among the 21 ciHHV-6B genomes (scaled to differences per 1,000 amino acids). The green dot shows the novel in-frame
stop codon in U14 of 1-ciHHV-6B. The pie chart shows the overall proportions of synonymous and nonsynonymous substitutions across all the genes. (B)
Diagram showing the approximate locations and consequences of nucleotide substitutions that are predicted to have arisen after integration in group 3
ciHHV-6B genomes. The horizontal line represents the HHV-6B genome; black dots, locations of noncoding base substitutions; red dots, base substitutions
within HHV-6B genes that are predicted to result in amino acid substitutions (nonsynonymous), as indicated; pink dot, synonymous (T-to-C) substitution in
DER512 that is not predicted to change the phenylalanine. The numbers of repeats in three regions (T2, R1, and R4) that vary among the group 3 genomes
are also shown.
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similar to each another than to the two available HHV-6B reference genomes from
Japan and the Democratic Republic of the Congo (Fig. 2, 3, and 4; see Fig. S1 in the
supplemental material). This is particularly noticeable among the 19 ciHHV-6B genomes
from individuals with European ancestry, which are more similar to each other than
they are to the ciHHV-6B genomes in HGDP00092 from Pakistan and HGDP00813 from
China. This pointer toward a relationship between the integrated HHV-6B strain and
geographical distribution warrants further investigation if the association between
carrier status and potential disease risk is to be understood fully (21, 38). The smaller
group of seven ciHHV-6A genomes show higher levels of divergence from the three
available HHV-6A reference genomes from the United States, Uganda, and the Gambia
and as reported previously (30). However, in making these observations, the possibility
of sample bias should be considered, both in the geographic distribution of the
ciHHV-6 genomes analyzed and, in particular, in the small number of nonintegrated
HHV-6A and HHV-6B genomes that are available for comparative analysis.
The isolation of chromosome junction fragments from eight ciHHV-6B samples
(seven group 3 samples and 1-ciHHV-6B) by using primers from chromosome 17p
subterminal sequences (35) suggests integration in alleles of the 17p telomere. Given
the variable nature of human subterminal regions (37), the chromosome locations
should be confirmed using a different approach. Nevertheless, comparison of the
TTAGGG and degenerate-repeat interspersion patterns at the chromosome–ciHHV-6B
junction can be used to deduce relationships (34, 39) and, combined with the phylo-
genetic analyses, shows that the individuals carrying a group 3 ciHHV-6B genome share
an ancient ancestor. Group 3 includes individuals from Sardinia, England, Wales, and
Orkney, with greater divergence between the ciHHV-6B genomes in the two individuals
from Sardinia (HGDP1065 and HGDP1077) than between the individual from Derby,
England (DER512), and the Sardinian (HGDP1065) (Fig. 3, 5, and 6 and Tables 1 and 3).
Moreover, there is no evidence of a close family relationship between the two individ-
uals from Sardinia. Overall, the data are consistent with the group 3 ciHHV-6B carriers
being descendants of a common ancestor who existed approximately 24,500 years ago,
similar to the date of the last glacial maximum and probably predating the colonization
of Sardinia and Orkney.
The population screen of Orkney identified 42 ciHHV-6B carriers (frequency, 1.9%)
(Table 2) and no ciHHV-6A carriers, which also suggests a founder effect. However, the
Orkney ciHHV-6B samples can be divided into two groups based on the length of
DRR-T1, the ciHHV-6B phylogenetic analyses, and the different integration sites. There-
fore, it is likely that the ciHHV-6B carriers in Orkney are the descendants of two different
ciHHV-6B ancestors who may have migrated to Orkney independently. This is consis-
tent with the fine-resolution genetic structure of the Orkney population and the history
of Orkney, which includes recent admixture from Norway (Norse Vikings) (36).
Given the evidence that extant ciHHV-6B carriers in group 3 are descendants of a
single ancient founder with a germ line integration, it is plausible that other clusters in
the phylogenetic tree have similar histories. For example, the three individuals in group
2 may all carry a ciHHV-6B genome integrated in a chromosome 11p telomere. Further
verification is required to support this speculation, and this will be valuable when
assessing disease risk associated with ciHHV-6 integrations in different telomeres.
There is good evidence that ciHHV-6 genomes can reactivate in some settings, for
example, when the immune system is compromised (19, 20). However, it is not known
what proportion of ciHHV-6 genomes may retain the capacity to reactivate. We
investigated this question from various angles. We have presented evidence that some
ciHHV-6 genomes are ancient and therefore could have accumulated inactivating
mutations while in the human genome. Most of the tandem repeats analyzed in
ciHHV-6B genomes showed minor variations in repeat copy numbers (Fig. 5 and Table
3). However, the functions of these regions are unclear, and as copy number variation
exists among the reference genomes, it seems unlikely that the level of variation
detected unduly influences the potential functionality of the integrated viral genomes.
In the protein-coding regions of ciHHV-6B genomes, 34% of substitutions are nonsyn-
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onymous and are predicted to cause amino acid substitutions (Fig. 7). A single
potentially inactivating mutation was detected as an in-frame stop codon in gene U14
in 1-ciHHV-6B. Since this gene encodes a tegument protein that is essential for the
production of viral particles and can induce cell cycle arrest at the G2/M phase (40), it
seems unlikely that this integrated copy of ciHHV-6B would be able to reactivate.
However, the other viral genes may be expressed in this ciHHV-6B genome, and the
presence of the viral genome may also affect telomere function. The stop codon in
gene U20 in the individual from Pakistan (HGDP00092) is mutated, and this is predicted
to extend the U20 protein by 8 amino acid residues. U20 is part of a cluster of genes
(U20 to U24) that are specific to HHV-6A, HHV-6B, and their relative human betaher-
pesvirus 7 and likely plays a role in suppressing an apoptotic response by the infected
host cell (41, 42). Further experimental analysis will be required to determine whether
the modest extension affects the function of the U20 protein. Among the seven
ciHHV-6A genomes, two contain novel in-frame stop codons. One of these is located in
U83 in GLA_4298. The other is present in U79 in GLA_15137, but this inactivating
mutation is absent from the closely related ciHHV-6A genome in 7A-17p13.3 (Fig. 3C
and D).
In summary, we have shown that most ciHHV-6A and ciHHV-6B genomes contain an
intact set of genes and therefore may have the potential to be fully functional. This
observation needs to be taken into consideration when assessing whether ciHHV-6
carrier status is associated with disease risk and in understanding the underlying
mechanisms of such associations (e.g., whether viral reactivation is involved). Among
the individuals of European descent, we found strong evidence for the ancient com-
mon ancestry of some of the integrated viral genomes. The close similarity between
ciHHV-6B genomes in the Europeans and the evidence of multiple different integration
events by similar strains also indicate that we have effectively sequenced the ancient,
nonintegrated strains of HHV-6B that existed in European populations in prehistoric
times. Based on these observations, it is possible that other populations, for example,
in China, South Asia, and Africa, may show similar founder effects among ciHHV-6
carriers but from different ancient strains (43). Our limited knowledge of nonintegrated
HHV-6A and HHV-6B strains is based mostly on strains derived from Africa and Japan.
There is now a real need to sequence nonintegrated strains from other populations,
including those in Europe, so that the relationship between nonintegrated HHV-6 and
ciHHV-6 can be fully understood. A major challenge will be to determine whether germ
line integration continues to occur de novo today and, if so, at what rate and by which
viral strains.
MATERIALS AND METHODS
Population screening to identify ciHHV-6 carriers. ciHHV-6 carriers were identified by screening a
variety of DNA sample collections from individuals from around the world, using PCR assays to detect
either U11, U18, DR5 (HHV-6A), or DR7 (HHV-6B) (12), or U7, DR1, DR6A, or DR6B (22 and unpublished
data). DR5, DR6A, DR6B, and DR7 correspond to ORFs in the original annotation of the HHV-6A genome
(GenBank accession no. X83413) (25), but DR5 is in a noncoding region of the genome, and DR6A, DR6B,
and DR7 are in exons of DR6 in the reannotation used (RefSeq accession no. NC_001664). From the
populations screened, 58 samples with ciHHV-6 among 3,875 individuals were identified (Table 2). The
number of individuals screened in most populations was small and therefore cannot be used to give an
accurate estimate of ciHHV-6A or -B frequencies, although a larger number of ciHHV-6B-positive samples
were identified overall. The frequency of ciHHV-6B carriers in Orkney (1.9%), a collection of islands off the
north coast of Scotland, is higher than that reported from England (44). Screening of the GS:SFHS will be
described elsewhere (R. F. Jarrett, unpublished data). Ethical approval for the GS:SFHS cohort was
obtained from the Tayside Committee on Medical Research Ethics (on behalf of the National Health
Service).
Generation of overlapping amplicons and sequencing. The 32 primer pairs used to generate
overlapping amplicons from ciHHV-6A genomes and the PCR conditions employed were reported
previously (18). The primer pairs used to amplify ciHHV-6B genomes were based on conserved sequences
from the HHV-6B nonintegrated HST and Z29 strains (GenBank accession no. AB021506.1 and AF157706,
respectively) (9, 24). The primer sequences are shown in Table S1 in the supplemental material. The
amplicons from each sample were pooled in equimolar proportions and then sequenced using the
Illumina MiSeq or IonTorrent (Life Technologies) next-generation sequencing platforms, as described
previously (18). Some sequences were verified by using Sanger dideoxy chain termination sequencing on
PCR-amplified products.
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Assembly and analysis of DNA sequence data. DNA sequence data were processed essentially as
described previously (18), except that SPAdes v. 3.5.0 (45) was used for de novo assembly into contigs,
ABACAS v. 1.3.1 (46) was used to order contigs, and Gapfiller v. 1-11 (47) was used to fill gaps between
contigs. The integrity of the sequences was verified by aligning them against the read data using BWA
v. 0.6.2-r126 (53) and visualizing the alignments as BAM files using Tablet v. 1.13.08.05 (52). Nucleotide
substitutions, indels, and repeat regions were also verified by manual analysis using IGV v. 2.3 (http://
software.broadinstitute.org/software/igv/home).
Alignments of the seven ciHHV-6A genomes with the three published HHV-6A genomes from the
nonintegrated strains U1102, GS, and AJ (25, 27–29) and alignment of the 21 ciHHV-6B genomes with the
two previously published HHV-6B genomes from the nonintegrated viruses HST and Z29 (9, 24) were
carried out using Gap4 (48). Variation across the ciHHV-6 genomes was studied by a combination of
manual inspection and automated analysis using an in-house Perl script. The script performed a
sliding-window count of substitutions using the aligned Gap4 files, reporting the count according to the
midpoint of the window. For analysis across the genome, the window size was 1 kb and the step size was
1 nucleotide. For analysis of individual ORFs, a file with a list of annotated positions was generated.
Phylogenetic analyses were carried out by two different methods. Maximum-likelihood trees were
built by using the maximum composite likelihood model (MEGA6.0), and bootstrap values were obtained
with 2,000 replications. Model selection was carried out for HHV-6A and HHV-6B separately, and the
substitution model with the lowest Bayesian information criterion was selected (the Tamura 3-parameter
model [49] for HHV-6B and the Hasegawa-Kishino-Yano model for HHV-6A). Median-joining networks
were built using Network 5.0 (Fluxus Engineering) with default parameters. Sites with missing data were
excluded from all phylogenetic analyses for both HHV-6A and HHV-6B. The number of positions analyzed
for HHV-6B was 130,412, and that for HHV-6A was 117,900. The TMRCA was calculated by using rho as
implemented in Network 5.0. Rho values were transformed into time values using the accepted mutation
rate for the human genome, 0.5E9 substitutions per bp per year (50), scaled to the number of sites
analyzed.
Comparison of tandem-repeat regions. The copy numbers of repeat units in the DR-R, R0, R1, R2,
R3, and R4 tandem-repeat regions (9, 24) were determined by manual inspection of the individual BAM
files generated for each sequenced ciHHV-6 genome, with verification by checking the sequence
alignments generated using Gap4. The number of copies of TTAGGG in each DRL-T2 region was
determined from PCR amplicons generated using the DR8F and UDL6R primers (see Table S1 in the
supplemental material). Each amplicon was purified using a Zymoclean gel DNA recovery kit (Cambridge
Bioscience) and then sequenced by the Sanger dideoxy chain termination method. The sequence data
were analyzed by using MacVector software (MacVector Inc.). Variation at the (CA)n repeat array located
immediately adjacent to T1 in HHV-6B was investigated in DRL specifically by reamplification of STELA
(51) products, using the primers DR1R and TJ1F. The short amplicons were purified and sequenced as
described above and compared with the same sequences in the reference HST and Z29 genomes.
Analysis of the DRR-T1 region by TVR-PCR. The DRR-T1 regions from ciHHV-6B-positive samples
were amplified using the primers U100Fw2 and DR1R. TVR-PCR was conducted on each of these
amplicons essentially as described previously (32, 33) but using an end-labeled primer, HHV-6B-UDR5F,
and the unlabeled TAG-TELWRev. The TELWRev primer anneals to TTAGGG repeats, allowing amplifica-
tion of products that differ in length depending on the location of the TTAGGG repeat with respect to
the flanking primer (HHV-6B-UDR5F). The labeled amplicons from the T1 region were separated by size
in a 6% denaturing polyacrylamide gel.
Analysis of HHV-6 ORFs. The frequency of nucleotide substitutions in each ORF was determined by
a combination of manual inspection and automated analysis using a Perl script, as described above. The
DNA sequences of the 86 HHV-6B ORFs from the 21 ciHHV-6B genomes were aligned to identify and
compare the numbers of synonymous and nonsynonymous codon changes within and among genes. In
addition, the predicted amino acid sequences for each gene in the 21 ciHHV-6B genomes were aligned
to confirm the number of nonsynonymous changes.
Characterization of chromosome-ciHHV-6 junctions. The junctions between the chromosome and
the ciHHV-6 genome were isolated by PCR amplification using various primers that anneal to subterminal
regions of a variety of human chromosomes in combination with the DR8F primer. The amplicons were
purified as described above and sequenced by the Sanger method with a variety of primers (see Table
S1 in the supplemental material). The number of repeats present in each junction fragment and the
interspersion of TTAGGG repeats with degenerate repeats was determined by manual inspection using
MacVector software.
Accession number(s). The finished sequences have been deposited in GenBank under accession
numbers KY316030 to KY316056 (Table 1). The LEI_1501 ciHHV-6A genome reported previously has
accession number KT355575 (18).
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